Stock Spotlight: ResMed Inc. (ASX:RMD)

This week's Stock Spotlight is ASX-listed ResMed Inc.


About ResMed Inc.


ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. It operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME) to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies; and MEDIFOX DAN's software solutions. The company markets its products to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force. The company was founded in 1989 and is headquartered in San Diego, California.



Source: Yahoo Finance



Key Stats

Source: Yahoo Finance. Data as of 07/08/25.


Price Performance

Growth Potential

  • Global leader in a significantly under-penetrated sleep apnea market. High barriers to entry in establishing global distribution channels.
  • Strong R&D program ensuring RMD remains ahead of competitors.
  • New product launches (momentum in new mask releases) & buildout of portfolio via bolt-on acquisitions is seeing RMD become the one-stop shop for sleep apnear.
  • Increasing popularity of GLP-1s is increasing awareness with studies indicating patients with an OSA diagnosis and prescribed a GLP-1 drug are 11% more likely to initiate PAP therapy.
  • Strong balance sheet and attractive free cash flow profile provides management significant strategic flexibility. 
  • Solid FY26 guidance with further upside to gross margin.
  • Capital management – active share buyback (shares to be repurchased expected at $150m per quarter for FY26).

Key Risks


  • Disruptive technology leads to better patient compliance or introduction of alternative therapies (GLP-1 weight loss drugs).
  • Product recall leading to reputational damage.
  • Competitive threats lead to market share loss – e.g. pharmaceutical threats to the CPAP market.
  • Disappointing growth (company and industry specific).
  • Adverse currency movements (AUD, EUR, USD).
  • Adverse changes in regulatory & government funding

Subscribe to our newsletter

Disclaimer: This article does not constitute financial advice nor a recommendation to invest in the securities listed. The information presented is intended to be of a factual nature only. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing.

Is a Share Advisor

right for you?

December 12, 2025
A clear look at how rare earths drive EVs, wind power and AI hardware, and what supply constraints mean for long-term investment themes.
December 11, 2025
About Medtronic Plc Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves, and percutaneous coronary intervention products, percutaneous angioplasty balloons, and other products. The Neuroscience Portfolio segment offers medical devices and implants, biologic solutions, spinal cord stimulation and brain modulation systems, implantable drug infusion systems, and interventional products, as well as nerve ablation system under the Accurian name. The segment offers its products for spinal surgeons, neurosurgeons, neurologists, pain management specialists, anesthesiologists, orthopedic surgeons, urologists, urogynecologists, and interventional radiologists, as well as ear, nose, and throat specialists, and energy surgical instruments. The Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure and electrosurgery products, AI-powered surgical video and analytics platform, robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology products, gastrointestinal and hepatologic diagnostics and therapies, and therapies to treat diseases and conditions, and patient monitoring and airway management products. The Diabetes Operating Unit segment provides insulin pumps and consumables, continuous glucose monitoring systems and sensors, and InPen, a smart insulin pen. Medtronic plc was founded in 1949 and is headquartered in Galway, Ireland. Key Stats
December 11, 2025
The Fed’s latest rate cut marks a key shift in policy. Explore its impact on global markets, inflation risks, and how investors should position heading into 2026.
December 11, 2025
About Waste Management Inc Waste Management, Inc., through its subsidiaries, provides environmental solutions to residential, commercial, industrial, and municipal customers in the United States, Canada, Western Europe, and internationally. It offers collection services, including picking up and transporting waste and recyclable materials from where it was generated to a transfer station, recovery facility, or disposal site; owns and operates transfer stations; and owns, develops, and operates landfill gas-to-energy facilities that produce renewable electricity and renewable natural gas. It also operates materials processing and commodities recycling services, including cardboard, paper, glass, metals, plastics, construction and demolition materials, and other recycling commodities are recovered for resale or redirected for other purposes; recycling brokerage services, such as managing the marketing of recyclable materials for third parties; and other strategic business solutions. In addition, the company collects recyclable food and yard waste, as well as markets and sells mulch, compost, soil amendments, and renewable energy; offers remediation and construction, and industrial waste services; and manages and markets fly ash. Further, it provides Regulated Waste and Compliance Services (RWCS), which offers compliance programs, as well as collection, processing, and disposal of regulated and specialized waste, including medical, pharmaceutical, and hazardous waste; and Secure Information Destruction (SID) services that includes the collection of personal and confidential information for secure destruction and recycling of sorted office paper. The company was formerly known as USA Waste Services, Inc. and changed its name to Waste Management, Inc. in 1998. Waste Management, Inc. was founded in 1968 and is based in Houston, Texas. Key Stats
December 9, 2025
How U.S.–China competition in semiconductors shapes AI, manufacturing, and global markets, and what investors need to know.
December 5, 2025
Insights on the Fed’s next move, market implications and what investors should expect heading into 2026.
December 2, 2025
As December unfolds, explore the Santa Claus Rally and uncover its drivers, risks, and potential impact on investors this year.
November 21, 2025
About Xero Ltd Xero Limited, together with its subsidiaries, provides online business solutions for small businesses and their advisors in Australia, New Zealand, the United Kingdom, North America, and internationally. It offers accounting, payroll, payments and other solutions through its Xero platform. The company also provides Planday, an online employee scheduling software; Hubdoc for bills and receipts; Syft, which creates reports, forecasts, dashboards, and consolidations with AI insights; TaxCycle, a tax preparation software for accountants and bookkeepers; and Tickstar, an e-invoicing product. Xero Limited was incorporated in 2006 and is headquartered in Wellington, New Zealand. Key Stats
November 20, 2025
Discover why Centuria shares are a top ASX income stock, offering stable dividends & growth potential. Stay informed on Centuria’s opportunities & risks.
November 20, 2025
Fortescue Ltd (FMG) stock insights: Explore growth, dividends, risks & investor strategies for long-term returns. Read our complete Stock Spotlight today!